Low-dose administration of oral pazopanib for the treatment of recurrent angiosarcoma

Clin Exp Dermatol. 2015 Jul;40(5):575-7. doi: 10.1111/ced.12575. Epub 2015 Mar 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage*
  • Female
  • Hemangiosarcoma / drug therapy*
  • Hemangiosarcoma / pathology
  • Humans
  • Indazoles
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Sulfonamides / administration & dosage*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Indazoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • pazopanib